ACNU Feasibility

View full report
GoodIngrezza is an oral capsule with moderate side effects and drug interactions, requiring careful monitoring and caution in special populations. It has low misuse risk, simple once-daily dosing, but potential adherence challenges due to side effects.

ACNU Feasibility Scorecard

Chart with 11 data points.
Ingrezza
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 6.
End of interactive chart.